New York State Teamsters Council Health & Hospital Fund v. Centrus Pharmacy Solutions

235 F. Supp. 2d 123, 29 Employee Benefits Cas. (BNA) 2222, 2002 U.S. Dist. LEXIS 24461, 2002 WL 31844712
CourtDistrict Court, N.D. New York
DecidedDecember 10, 2002
Docket5:02-cv-00560
StatusPublished
Cited by43 cases

This text of 235 F. Supp. 2d 123 (New York State Teamsters Council Health & Hospital Fund v. Centrus Pharmacy Solutions) is published on Counsel Stack Legal Research, covering District Court, N.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
New York State Teamsters Council Health & Hospital Fund v. Centrus Pharmacy Solutions, 235 F. Supp. 2d 123, 29 Employee Benefits Cas. (BNA) 2222, 2002 U.S. Dist. LEXIS 24461, 2002 WL 31844712 (N.D.N.Y. 2002).

Opinion

MEMORANDUM-DECISION and ORDER

HURD, District Judge.

I. INTRODUCTION

On May 28, 2002, the plaintiffs commenced the instant action against defendant claiming three causes of action: (1) that defendant Centrus Pharmacy Solutions breached its fiduciary duty to the New York State Teamsters Council Health and Hospital Fund (the “Fund”) under the Employee Retirement Income Security Act, 29 U.S.C. § 1001, et. seq. (“ERISA”); (2) that defendant engaged in a prohibited transaction with the Fund in violation of 29 U.S.C. § 1106(a); and (3) state common law breach of contract.

Defendant moves to dismiss the Complaint pursuant to Fed.R.Civ.P. 12(b)(6). Plaintiff opposes. Oral argument was heard on October 25, 2002 in Albany, New York. Decision was reserved.

II. FACTS

The Fund is an employee benefit plan under 29 U.S.C. § 1002(3). (Compl. at ¶ 4.) In or about November 1992, the Fund entered into a Prescription Drug Services Agreement (the “Agreement”) with defendant. (Compl. at ¶ 6; Compl. at Ex. A.) Pursuant to the Agreement, defendant was required to:

1. Prepare and issue identification cards to Fund participants;
*125 2. Verify eligibility of participants in the Fund’s prescription drug program;
3. Pay the prescription cost of drugs falling within certain categories;
4. Maintain a central pharmacy for the use of Fund members;
5. Process claims and verify that prescriptions fell within the scope of the prescription drug program;
6. Verify the price computation of each prescription;
7. Design and supply forms from the prescription drug program;
8. Submit statements of charges and bi-weekly reports;
9. Maintain records for compliance with Internal Revenue Service regulations and ERISA;
10. Accumulate statistics for the Fund;
11. Provide reports to the Fund;
12. Provide recommendations for changes in the prescription drug program, including adoption of a “preferred drug formulary”;
13. Maintain a file for each participant in the Fund’s prescription drug program;
14. Provide the Fund with the necessary data to comply with the Health Plan Employer Data and Information Set and National Committee on Quality Assurance guidelines;
15. Create and maintain a computerized system for administering the prescription drug program;
16. Arrange for the payment of qualified prescription drug claims through a network of pharmacies;
17. Determine whether claims qualified for reimbursement in accordance with the relevant and controlling documents;
18. Provide general pharmacy benefit services associated with claims processing, network and prescription benefit management, and mail service provisions of prescription drugs; and
19. Maintain a network of provider pharmacies.

(Compl. at ¶ 8.) In exchange, the Fund paid defendant sixty-two cents for each claim it processed.

In January 1999, defendant recommended a preferred formulary program (the “program”) to the Fund. Under the program, Fund participants would be encouraged to use cheaper, preferred, formu-lary drugs for which they would be responsible for paying a $4.00 co-payment, rather than the standard $8.00 co-payment applicable to non-formulary, single source brand name drugs. (Compl. at ¶¶ 10-11.) The Fund adopted the recommendation and implemented it on May 1, 1999. (Compl. at ¶ 13.)

In implementing the plan, defendant improperly reduced the co-payment for all drugs (including non-formulary, single source brand name drugs) to $4.00. (Compl. at ¶ 14.) Because of this error, the Fund only collected $4.00 for many drugs on which it should have collected $8.00. (Id. at ¶ 15.) Accordingly, the Fund lost $4.00 on each non-formulary drug claim processed by defendant. (Id.) The Agreement was terminated on December 31, 2000. (Id. at ¶ 7.)

III. STANDARD OF REVIEW

In deciding a Rule 12(b)(6) motion, a court “must accept the allegations contained in the complaint as true, and draw all reasonable inferences in favor of the non-movant; it should not dismiss the complaint ‘unless it appears beyond a rea *126 sonable doubt that the plaintiffs] can prove no set of facts in support of [their] claim which would entitle [them] to relief.’ ” Sheppard v. Beerman, 18 F.3d 147, 150 (2d Cir.) (quoting Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957)), cert. denied, 513 U.S. 816, 115 S.Ct. 73, 130 L.Ed.2d 28 (1994); see also Kaluczky v. City of White Plains, 57 F.3d 202, 206 (2d Cir.1995). Conclusory allegations that merely state the general legal conclusions necessary to prevail on the merits and are unsupported by factual averments will not be accepted as true. See, e.g., Clapp v. Greene, 743 F.Supp. 273, 276 (S.D.N.Y.1990), aff'd, 930 F.2d 912 (2d Cir.), cert. denied, 502 U.S. 868, 112 S.Ct. 197, 116 L.Ed.2d 157 (1991); Albert v. Carovano, 851 F.2d 561, 572 (2d Cir.1988). “ ‘A court may dismiss a complaint [under Fed.R.Civ.P. 12] only if it is clear that no relief could be granted under any set of facts that could be proved consistent with the allegations.’ ” Swierkiewicz v. Sorema N.A., 534 U.S. 506, 122 S.Ct. 992, 152 L.Ed.2d 1 (2002) (quoting Hishon v. King & Spalding, 467 U.S. 69, 73, 104 S.Ct.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
235 F. Supp. 2d 123, 29 Employee Benefits Cas. (BNA) 2222, 2002 U.S. Dist. LEXIS 24461, 2002 WL 31844712, Counsel Stack Legal Research, https://law.counselstack.com/opinion/new-york-state-teamsters-council-health-hospital-fund-v-centrus-pharmacy-nynd-2002.